Arrowgrass Capital Partners (US)’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q3
Sell
-478,854
Closed -$8.78M 219
2015
Q2
$8.78M Buy
+478,854
New +$8.78M 0.13% 79